Michael J. Birrer, MD, PhD, discusses the introduction of poly ADP-ribose polymerase inhibitors to the ovarian cancer treatment landscape.
Jessica D'Amico
Articles by Jessica D'Amico
Latest Updated Articles
PARP Inhibitors Offer Hope for Patients With Ovarian CancerPublished: September 21st 2017 | Updated: April 18th 2020